We use cookies to analyze the performance of our website. If you continue to visit our website you are consenting to our use of cookies.

Yes No More Info

ICRC-Weyer To Monitor Advanced Therapy Trials

ICRC-Weyer GmbH has recently extended its clinical monitoring services portfolio to monitoring for trials in the area of stem cell research. The enhanced portfolio enables the German all-phase CRO to serve the demands of the global pharmaceutical industry in the growing field of regenerative medicine. On May 10, 2012, a group of representatives from ICRC-Weyer GmbH attended a colloquium on regulatory requirements for the development of cell-based medicine which took place at Beuth University in Berlin, Germany (Clinical Trial Management Colloquium).

We use cookies to analyze the performance of our website. If you continue to visit our website you are consenting to our use of cookies.

Yes No More Info